Health Care & Life Sciences » Pharmaceuticals | iCo Therapeutics Inc.

iCo Therapeutics Inc.

iCo Therapeutics Inc.
Stock Exchange Other OTC
EPS
$0.02
Market Cap
$4.82 M
Shares Outstanding
84.46 M
Public Float
-
iCo Therapeutics Inc.
Stock Exchange Toronto Ventures Stock Exchange
EPS
CAD0.02
Market Cap
CAD6.02 M
Shares Outstanding
109.46 M
Public Float
100.11 M

Profile

Address
777 Hornby Street
Vancouver British Columbia V6Z 2T3
Canada
Employees -
Website http://www.icotherapeutics.com
Updated 07/08/2019
iCo Therapeutics, Inc. engages in the business of identification, development and commercialization of drug candidates for the treatment of sight- and life-threatening diseases. Its products include iCo-008 and oral AmpB delivery system. The company was founded by Andrew J.

Financials

View All

Andrew J. Rae
President, Chief Executive Officer & Director
Michael Liggett
Chief Financial Officer, Secretary & Director